1. Home
  2. ETON vs SPTX Comparison

ETON vs SPTX Comparison

Compare ETON & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$62.53

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$26.97

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETON
SPTX
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
ETON
SPTX
Price
$62.53
$26.97
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$39.33
N/A
AVG Volume (30 Days)
626.9K
107.2K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$79,950,000.00
N/A
Revenue This Year
$40.90
N/A
Revenue Next Year
$47.23
N/A
P/E Ratio
$152.73
N/A
Revenue Growth
104.94
N/A
52 Week Low
$14.27
$17.59
52 Week High
$66.37
$28.37

Technical Indicators

Market Signals
Indicator
ETON
SPTX
Relative Strength Index (RSI) 70.36 77.83
Support Level $15.66 $18.72
Resistance Level N/A N/A
Average True Range (ATR) 3.41 1.68
MACD 0.75 0.34
Stochastic Oscillator 86.65 96.68

Price Performance

Historical Comparison
ETON
SPTX

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: